Industry Research Reports

Home > Reports > Medical Care > Alpha Thalassemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Alpha Thalassemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 71 Pages

Report ld: 2339330

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of red blood cells. This ultimately leads to anemia. There are two main types of thalassemia: alpha-thalassemia and beta-thalassemia, the latter being more serious. Beta-thalassemia is a common autosomal recessive disorder worldwide and it is relatively rare in U.S.

The global market for Alpha Thalassemia was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Alpha Thalassemia, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Alpha Thalassemia by region & country, by Type, and by Application.

The Alpha Thalassemia market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha Thalassemia.

Market Segmentation

Report Metric
Details
Report Title
Alpha Thalassemia - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Alpha Thalassemia Companies Covered
Bluebird Bio, Novartis, Kiadis Pharma, Acceleron Pharma
Global Alpha Thalassemia Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alpha Thalassemia Market, Segment by Type
Iron Chelating Drugs

Gene Therapy
Global Alpha Thalassemia Market, Segment by Application
Hospitals

Private Clinics

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Alpha Thalassemia manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Alpha Thalassemia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Alpha Thalassemia in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Alpha Thalassemia Product Introduction
    1.2 Global Alpha Thalassemia Market Size Forecast
    1.3 Alpha Thalassemia Market Trends & Drivers
        1.3.1 Alpha Thalassemia Industry Trends
        1.3.2 Alpha Thalassemia Market Drivers & Opportunity
        1.3.3 Alpha Thalassemia Market Challenges
        1.3.4 Alpha Thalassemia Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Alpha Thalassemia Players Revenue Ranking (2023)
    2.2 Global Alpha Thalassemia Revenue by Company (2019-2024)
    2.3 Key Companies Alpha Thalassemia Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Alpha Thalassemia Product Offered
    2.5 Key Companies Time to Begin Mass Production of Alpha Thalassemia
    2.6 Alpha Thalassemia Market Competitive Analysis
        2.6.1 Alpha Thalassemia Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Alpha Thalassemia Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Thalassemia as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Iron Chelating Drugs
        3.1.2 Gene Therapy
    3.2 Global Alpha Thalassemia Sales Value by Type
        3.2.1 Global Alpha Thalassemia Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Alpha Thalassemia Sales Value, by Type (2019-2030)
        3.2.3 Global Alpha Thalassemia Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Private Clinics
        4.1.3 Other
    4.2 Global Alpha Thalassemia Sales Value by Application
        4.2.1 Global Alpha Thalassemia Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Alpha Thalassemia Sales Value, by Application (2019-2030)
        4.2.3 Global Alpha Thalassemia Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Alpha Thalassemia Sales Value by Region
        5.1.1 Global Alpha Thalassemia Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Alpha Thalassemia Sales Value by Region (2019-2024)
        5.1.3 Global Alpha Thalassemia Sales Value by Region (2025-2030)
        5.1.4 Global Alpha Thalassemia Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Alpha Thalassemia Sales Value, 2019-2030
        5.2.2 North America Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Alpha Thalassemia Sales Value, 2019-2030
        5.3.2 Europe Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Alpha Thalassemia Sales Value, 2019-2030
        5.4.2 Asia Pacific Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Alpha Thalassemia Sales Value, 2019-2030
        5.5.2 South America Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Alpha Thalassemia Sales Value, 2019-2030
        5.6.2 Middle East & Africa Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Alpha Thalassemia Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Alpha Thalassemia Sales Value
    6.3 United States
        6.3.1 United States Alpha Thalassemia Sales Value, 2019-2030
        6.3.2 United States Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Alpha Thalassemia Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Alpha Thalassemia Sales Value, 2019-2030
        6.4.2 Europe Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Alpha Thalassemia Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Alpha Thalassemia Sales Value, 2019-2030
        6.5.2 China Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Alpha Thalassemia Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Alpha Thalassemia Sales Value, 2019-2030
        6.6.2 Japan Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Alpha Thalassemia Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Alpha Thalassemia Sales Value, 2019-2030
        6.7.2 South Korea Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Alpha Thalassemia Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Alpha Thalassemia Sales Value, 2019-2030
        6.8.2 Southeast Asia Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Alpha Thalassemia Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Alpha Thalassemia Sales Value, 2019-2030
        6.9.2 India Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Alpha Thalassemia Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bluebird Bio
        7.1.1 Bluebird Bio Profile
        7.1.2 Bluebird Bio Main Business
        7.1.3 Bluebird Bio Alpha Thalassemia Products, Services and Solutions
        7.1.4 Bluebird Bio Alpha Thalassemia Revenue (US$ Million) & (2019-2024)
        7.1.5 Bluebird Bio Recent Developments
    7.2 Novartis
        7.2.1 Novartis Profile
        7.2.2 Novartis Main Business
        7.2.3 Novartis Alpha Thalassemia Products, Services and Solutions
        7.2.4 Novartis Alpha Thalassemia Revenue (US$ Million) & (2019-2024)
        7.2.5 Novartis Recent Developments
    7.3 Kiadis Pharma
        7.3.1 Kiadis Pharma Profile
        7.3.2 Kiadis Pharma Main Business
        7.3.3 Kiadis Pharma Alpha Thalassemia Products, Services and Solutions
        7.3.4 Kiadis Pharma Alpha Thalassemia Revenue (US$ Million) & (2019-2024)
        7.3.5 Acceleron Pharma Recent Developments
    7.4 Acceleron Pharma
        7.4.1 Acceleron Pharma Profile
        7.4.2 Acceleron Pharma Main Business
        7.4.3 Acceleron Pharma Alpha Thalassemia Products, Services and Solutions
        7.4.4 Acceleron Pharma Alpha Thalassemia Revenue (US$ Million) & (2019-2024)
        7.4.5 Acceleron Pharma Recent Developments

 8 Industry Chain Analysis
    8.1 Alpha Thalassemia Industrial Chain
    8.2 Alpha Thalassemia Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Alpha Thalassemia Sales Model
        8.5.2 Sales Channel
        8.5.3 Alpha Thalassemia Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Alpha Thalassemia Market Trends
    Table 2. Alpha Thalassemia Market Drivers & Opportunity
    Table 3. Alpha Thalassemia Market Challenges
    Table 4. Alpha Thalassemia Market Restraints
    Table 5. Global Alpha Thalassemia Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Alpha Thalassemia Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Alpha Thalassemia Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Alpha Thalassemia Product Type
    Table 9. Key Companies Time to Begin Mass Production of Alpha Thalassemia
    Table 10. Global Alpha Thalassemia Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha Thalassemia as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Alpha Thalassemia Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Alpha Thalassemia Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Alpha Thalassemia Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Alpha Thalassemia Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Alpha Thalassemia Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Alpha Thalassemia Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Alpha Thalassemia Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Alpha Thalassemia Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Alpha Thalassemia Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Alpha Thalassemia Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Alpha Thalassemia Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Alpha Thalassemia Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Alpha Thalassemia Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Alpha Thalassemia Sales Value by Region (2019-2024) & (%)
    Table 27. Global Alpha Thalassemia Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Alpha Thalassemia Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Alpha Thalassemia Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Alpha Thalassemia Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bluebird Bio Basic Information List
    Table 32. Bluebird Bio Description and Business Overview
    Table 33. Bluebird Bio Alpha Thalassemia Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Alpha Thalassemia Business of Bluebird Bio (2019-2024)
    Table 35. Bluebird Bio Recent Developments
    Table 36. Novartis Basic Information List
    Table 37. Novartis Description and Business Overview
    Table 38. Novartis Alpha Thalassemia Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Alpha Thalassemia Business of Novartis (2019-2024)
    Table 40. Novartis Recent Developments
    Table 41. Kiadis Pharma Basic Information List
    Table 42. Kiadis Pharma Description and Business Overview
    Table 43. Kiadis Pharma Alpha Thalassemia Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Alpha Thalassemia Business of Kiadis Pharma (2019-2024)
    Table 45. Kiadis Pharma Recent Developments
    Table 46. Acceleron Pharma Basic Information List
    Table 47. Acceleron Pharma Description and Business Overview
    Table 48. Acceleron Pharma Alpha Thalassemia Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Alpha Thalassemia Business of Acceleron Pharma (2019-2024)
    Table 50. Acceleron Pharma Recent Developments
    Table 51. Key Raw Materials Lists
    Table 52. Raw Materials Key Suppliers Lists
    Table 53. Alpha Thalassemia Downstream Customers
    Table 54. Alpha Thalassemia Distributors List
    Table 55. Research Programs/Design for This Report
    Table 56. Key Data Information from Secondary Sources
    Table 57. Key Data Information from Primary Sources
    Table 58. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Alpha Thalassemia Product Picture
    Figure 2. Global Alpha Thalassemia Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Alpha Thalassemia Sales Value (2019-2030) & (US$ Million)
    Figure 4. Alpha Thalassemia Report Years Considered
    Figure 5. Global Alpha Thalassemia Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Alpha Thalassemia Revenue in 2023
    Figure 7. Alpha Thalassemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Iron Chelating Drugs Picture
    Figure 9. Gene Therapy Picture
    Figure 10. Global Alpha Thalassemia Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Alpha Thalassemia Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospitals
    Figure 13. Product Picture of Private Clinics
    Figure 14. Product Picture of Other
    Figure 15. Global Alpha Thalassemia Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Alpha Thalassemia Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Alpha Thalassemia Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Alpha Thalassemia Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Alpha Thalassemia Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Alpha Thalassemia Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Alpha Thalassemia Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Alpha Thalassemia Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Alpha Thalassemia Sales Value (%), (2019-2030)
    Figure 28. United States Alpha Thalassemia Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Alpha Thalassemia Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Alpha Thalassemia Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Alpha Thalassemia Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Alpha Thalassemia Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Alpha Thalassemia Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Alpha Thalassemia Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Alpha Thalassemia Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Alpha Thalassemia Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Alpha Thalassemia Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Alpha Thalassemia Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Alpha Thalassemia Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Alpha Thalassemia Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Alpha Thalassemia Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Alpha Thalassemia Sales Value by Application (%), 2023 VS 2030
    Figure 49. Alpha Thalassemia Industrial Chain
    Figure 50. Alpha Thalassemia Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation

Description

Thalassemia is a general term for a group of inheritable blood disorders, in which the body produces abnormal hemoglobin, resulting in destruction of red blood cells. This ultimately leads to anemia. There are two main types of thalassemia: alpha-thalassemia and beta-thalassemia, the latter being more serious. Beta-thalassemia is a common autosomal recessive disorder worldwide and it is relatively rare in U.S.

The global market for Alpha Thalassemia was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Alpha Thalassemia, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Alpha Thalassemia by region & country, by Type, and by Application.

The Alpha Thalassemia market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha Thalassemia.

Market Segmentation